In 2014, the Energy & Commerce Committee (E&C) Chairman, Fred Upton (R-MI-6), and Representative Diana DeGette (D-CO-1) embarked on an ambitious and bipartisan effort to improve our nation’s biomedical research and innovation system.
Living Donor Protection Act issue brief
The Living Donor Protection Act will eliminate barriers to living donation and increase access to lifesaving transplants.
Voices of PKD
Polycystic kidney disease (PKD) is one of the most common, life-threatening genetic diseases affecting thousands in America and millions worldwide. Learn more about those affected by PKD and their experiences.
Polycystic kidney disease (PKD) is one of the most common, life-threatening genetic diseases. It affects thousands in America and millions worldwide, who are in urgent need of treatments and a cure.
Kidney disease by the numbers
America’s under-recognized kidney disease epidemic highlights the imperative need to improve care, quality of life and clinical outcomes for millions of people living with this disease.
Congressional Kidney Caucus
The purpose of the Caucus is to educate Congress and the public about the problem kidney disease poses for our society and to educate Congress and the public about the federal government’s singular role in providing access to life-sustaining treatment for those Americans with the severest form of chronic kidney disease (CKD), stage 5 CKD.
Investing in kidney research is crucial to improve the cost-effectiveness of kidney care and clinical outcomes of the more than 20 million Americans with kidney disease.
Know when change happens
This is such an exciting time for PKD science! Advancements in PKD research are bountiful and we have the scoop to keep you up to date.